Heritable T-cell malignancy models established in a zebrafish phenotypic screen

Leukemia

Volumn 23, Issue 10, 2009, Pages 1825-1835

  Frazer, J K ^a   Meeker, N D ^a   Rudner, L ^a   Bradley, D F ^a   Smith, A C H ^a   Demarest, B ^a   Joshi, D ^a   Locke, E E ^a   Hutchinson, S A ^a   Tripp, S ^b   Perkins, S L ^a,b   Trede, N S ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b ARUP LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; NOTCH RECEPTOR; NOTCH1 RECEPTOR; T LYMPHOCYTE RECEPTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMICAL MUTAGENESIS; CHROMOSOME REARRANGEMENT; CONTROLLED STUDY; DISEASE TRANSMISSION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HETEROZYGOTE; LYMPHOBLASTOMA; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; ZEBRA FISH;

EID: 70350116790     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2009.116     Document Type: Article

References (47)

1. Silverman LB, Sallan SE. Newly diagnosed childhood acute lymphoblastic leukemia: Update on prognostic factors and treatment. Curr Opin Hematol 2003; 10: 290-296.
2. Gaynon PS, Trigg ME, Heerema NA, Sensel MG, Sather HN, Hammond GD et al. Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995. Leukemia 2000; 14: 2223-2233.
3. Thiel E, Kranz BR, Raghavachar A, Bartram CR, Loffler H, Messerer D et al. Prethymic phenotype and genotype of pre-T (CD7+/ER-)-cell leukemia and its clinical significance within adult acute lymphoblastic leukemia. Blood 1989; 73: 1247-1258.
4. Goldberg JM, Silverman LB, Levy DE, Dalton VK, Gelber RD, Lehmann L et al. Childhood T-cell acute lymphoblastic leukemia: The Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience. J Clin Oncol 2003; 21: 3616-3622.
5. Pui CH. Recent advances in the biology and treatment of childhood acute lymphoblastic leukemia. Curr Opin Hematol 1998; 5: 292-301.
6. Larson RA, Dodge RK, Linker CA, Stone RM, Powell BL, Lee EJ et al. A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111. Blood 1998; 92: 1556-1564.
7. Takeuchi J, Kyo T, Naito K, Sao H, Takahashi M, Miyawaki S et al. Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: The JALSG-ALL93 study. Leukemia 2002; 16: 1259-1266.
8. Gilliland DG. Hematologic malignancies. Curr Opin Hematol 2001; 8: 189-191.
9. Ferrando AA, Neuberg DS, Staunton J, Loh ML, Huard C, Raimondi SC et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 2002; 1: 75-87.
10. Pui CH, Relling MV, Downing JR. Acute lymphoblastic leukemia. N Engl J Med 2004; 350: 1535-1548.
11. Armstrong SA, Look AT. Molecular genetics of acute lymphoblastic leukemia. J Clin Oncol 2005; 23: 6306-6315.
12. Ferrando AA, Look AT. Clinical implications of recurring chromosomal and associated molecular abnormalities in acute lymphoblastic leukemia. Semin Hematol 2000; 37: 381-395.
13. Harrison CJ, Foroni L. Cytogenetics and molecular genetics of acute lymphoblastic leukemia. Rev Clin Exp Hematol 2002; 6: 91-113; discussion 200-2.
14. Graux C, Cools J, Michaux L, Vandenberghe P, Hagemeijer A. Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: From thymocyte to lymphoblast. Leukemia 2006; 20: 1496-1510.
15. Weng AP, Ferrando AA, Lee W, Morris JPt, Silverman LB, Sanchez-Irizarry C et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 2004; 306: 269-271.
16. Palomero T, Lim WK, Odom DT, Sulis ML, Real PJ, Margolin A et al. NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. Proc Natl Acad Sci USA 2006; 103: 18261-18266.
17. Gunz FW, Gunz JP, Veale AM, Chapman CJ, Houston IB. Familial leukaemia: a study of 909 families. Scand J Haematol 1975; 15: 117-131.
18. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 1994; 86: 1600-1608.
19. Horwitz M. The genetics of familial leukemia. Leukemia 1997; 11 1347-1359.
20. Segel GB, Lichtman MA. Familial (inherited) leukemia, lymphoma, and myeloma: An overview. Blood Cells Mol Dis 2004; 32: 246-261.
21. Benson KF, Horwitz M. Familial leukemia. Best Pract Res Clin Haematol 2006; 19: 269-279.
22. Amatruda JF, Zon LI. Dissecting hematopoiesis and disease using the zebrafish. Dev Biol 1999; 216: 1-15.
23. Trede NS, Langenau DM, Traver D, Look AT, Zon LI. The use of zebrafish to understand immunity. Immunity 2004; 20: 367-379.
24. Meeker ND, Trede NS. Immunology and zebrafish: Spawning new models of human disease. Dev Comp Immunol 2008; 32: 745-757.
25. Langenau DM, Traver D, Ferrando AA, Kutok JL, Aster JC, Kanki JP et al. Myc-induced T cell leukemia in transgenic zebrafish. Science 2003; 299: 887-890.
26. Chen J, Jette C, Kanki JP, Aster JC, Look AT, Griffin JD. NOTCH1-induced T-cell leukemia in transgenic zebrafish. Leukemia 2007; 21: 462-471.
27. Solnica-Krezel L, Schier AF, Driever W. Efficient recovery of ENU-induced mutations from the zebrafish germline. Genetics 1994; 136: 1401-1420.
28. Streisinger G, Walker C, Dower N, Knauber D, Singer F. Production of clones of homozygous diploid zebra fish (Brachydanio rerio). Nature 1981; 291: 293-296.
29. Gestl EE, Kauffman EJ, Moore JL, Cheng KC. New conditions for generation of gynogenetic half-tetrad embryos in the zebrafish (Danio rerio). J Hered 1997; 88: 76-79.
30. Bertrand JY, Kim AD, Violette EP, Stachura DL, Cisson JL, Traver D. Definitive hematopoiesis initiates through a committed erythromyeloid progenitor in the zebrafish embryo. Development 2007; 134: 4147-4156.
31. Traver D, Paw BH, Poss KD, Penberthy WT, Lin S, Zon LI. Transplantation and in vivo imaging of multilineage engraftment in zebrafish bloodless mutants. Nat Immunol 2003; 4: 1238-1246.
32. Langenau DM, Ferrando AA, Traver D, Kutok JL, Hezel JP, Kanki JP et al. In vivo tracking of T cell development, ablation, and engraftment in transgenic zebrafish. Proc Natl Acad Sci USA 2004; 101: 7369-7374.
33. Haffter P, Granato M, Brand M, Mullins MC, Hammerschmidt M, Kane DA et al. The identification of genes with unique and essential functions in the development of the zebrafish, Danio rerio. Development 1996; 123: 1-36.
34. Geisler R, Rauch GJ, Geiger-Rudolph S, Albrecht A, van Bebber F, Berger A et al. Large-scale mapping of mutations affecting zebrafish development. BMC Genomics 2007; 8: 11.
35. Trede NS, Ota T, Kawasaki H, Paw BH, Katz T, Demarest B et al. Zebrafish mutants with disrupted early T-cell and thymus development identified in early pressure screen. Dev Dyn 2008; 237: 2575-2584.
36. Lutzner M, Edelson R, Schein P, Green I, Kirkpatrick C, Ahmed A. Cutaneous T-cell lymphomas: The Sezary syndrome, mycosis fungoides, and related disorders. Ann Intern Med 1975; 83: 534-552.
37. Hicks J, Mierau GW. The spectrum of pediatric tumors in infancy, childhood, and adolescence: A comprehensive review with emphasis on special techniques in diagnosis. Ultrastruct Pathol 2005; 29 175-202.
38. Borowitz MJ, Chan JKC. T-lymphoblastic leukaemia/lymphoma. In: Swerdlow SH, Campos E, Harris NL, Jaffe EF, Pileri SA, Stein H, Thiele J, Vardiman JW (eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press: Lyon, 2008, pp 176-178.
39. Fay D, Spencer A. Genetic mapping and manipulation: Chapter 8 - dominant mutations. In: Community TCER (ed). Wormbook: Wormbook; February 17, 2006.
40. Zhuravleva J, Paggetti J, Martin L, Hammann A, Solary E, Bastie JN et al. MOZ/TIF2-induced acute myeloid leukaemia in transgenic fish. Br J Haematol 2008; 143: 378-382.
41. Sabaawy HE, Azuma M, Embree LJ, Tsai HJ, Starost MF, Hickstein DD. TEL-AML1 transgenic zebrafish model of precursor B cell acute lymphoblastic leukemia. Proc Natl Acad Sci USA 2006; 103: 15166-15171.
42. Scott RH, Homfray T, Huxter NL, Mitton SG, Nash R, Potter MN et al Familial T-cell non-Hodgkin lymphoma caused by biallelic MSH2 mutations. J Med Genet 2007; 44: E83.
43. Langenau DM, Jette C, Berghmans S, Palomero T, Kanki JP, Kutok JL et al. Suppression of apoptosis by bcl-2 overexpression in lymphoid cells of transgenic zebrafish. Blood 2005; 105: 3278-3285.
44. Bernt KM, Armstrong SA. Leukemia stem cells and human acute lymphoblastic leukemia. Semin Hematol 2009; 46: 33-38.
45. Traver D, Winzeler A, Stern HM, Mayhall EA, Langenau DM, Kutok JL et al. Effects of lethal irradiation in zebrafish and rescue by hematopoietic cell transplantation. Blood 2004; 104: 1298-1305.
46. Tropepe V, Coles BL, Chiasson BJ, Horsford DJ, Elia AJ, McInnes RR et al. Retinal stem cells in the adult mammalian eye. Science 2000; 287: 2032-2036.
47. Langenau DM, Keefe MD, Storer NY, Jette CA, Smith AC, Ceol CJ et al Co-injection strategies to modify radiation sensitivity and tumor initiation in transgenic Zebrafish. Oncogene 2008; 27: 4242-4248.